Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digitalkalender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English
Therapeutic decisions in multiple sclerosis moving beyond efficacy
Multiple Sclerosis
Jahr
Publikationsjahr
2013
Autoren
Autorenliste der Publikation
Brück W, Gold R, Lund BT, Oreja-Guevara C, Prat A, Spencer CM, Steinman L, Tintoré M, Vollmer TL, Weber MS, Weiner LP, Ziemssen T, Zamvil SS.
Verlag
Publisher-Information
JAMA Neurol. 2013 Oct;70(10):1315-24.
Link
Zur Publikation (externer Server)
https://doi.org/10.1001/jamaneurol.2013.3510
Tags
Forschungsthemen
Multiple Sklerose
MSZ
2013
Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomes
MASC
Jahr
2025
Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis
NIL
Jahr
2025
Education Research: Can Large Language Models Match MS Specialist Training?
MASC
Jahr
2025
A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis
MS Treatments
Jahr
2025
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis
NIL
Jahr
2025
